Tuesday, March 23, 2021 5:36:03 PM
1:52 PM ET 3/23/21 | BusinessWire
Peace of mind in casual settings during transition to maskless normalcy
PLANO, Texas--(BUSINESS WIRE)--March 23, 2021--
Mentor Capital, Inc. (OTCQB: MNTR) announced that any shareholder may receive a metal lapel pin at no cost from Mentor Capital, that is intended to self-indicate for casual situations that the wearer has been vaccinated with the Pfizer, Inc., Moderna, Inc. or AstraZeneca, PLC vaccines. The one inch pin reads "Covid-19 Antibodies" and is intended to give greater peace of mind in supermarkets, restaurants and other casual settings. This allows the wearer to unofficially but easily represent that they are vaccinated. Like an "I Voted" sticker, the pin may also help promote increased vaccine participation in areas where the government and businesses are already transitioning from a masked to a maskless environment.
Mentor shareholders may obtain the lapel pin free of charge by sending a self-addressed stamped return envelope to the company address: Mentor Capital, Inc., 5964 Campus Court, Plano, Texas 75093. The pins are sourced through "Antibody Badge" a non-profit that Mentor has sponsored to help support the anti-Covid-19 effort. Any person may request a free AntiBody Badge pin by asking for one in writing, sent to the company address, and including a self-addressed, stamped, return envelope. The offer is open as long as supplies last.
About Mentor Capital: The Company seeks to come alongside and assist private companies and their founders in meeting their liquidity and financial objectives, to add protection for investors, and to help incubate private companies. Additional important information for investors is presented at: www.MentorCapital.com
This press release is neither an offer to sell nor a solicitation of offers to purchase securities.
The Company undertakes no obligation to update or revise these statements to reflect new information, events, or circumstances occurring after this press release date.
View source version on businesswire.com: https://www.businesswire.com/news/home/20210323005939/en/
CONTACT: Mentor Capital, Inc.
Chet Billingsley, CEO
(760) 788-4700
info@mentorcapital.com
SOURCE: Mentor Capital, Inc.
Copyright Business Wire 2021
Recent MNTR News
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/18/2023 09:57:59 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/13/2023 07:51:23 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/13/2023 08:31:53 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/10/2023 06:05:30 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/11/2023 09:23:40 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM